Medtronic secured approval from the US Food and Drug Administration (FDA) for its closed-loop spinal cord stimulation (SCS) device, designed to adjust stimulation in real-time, for the treatment ...

Shares in the company were up 7% at market open following the first approval for a non-invasive spinal cord stimulator for ...

Spinal cord stimulation (SCS) therapies for chronic ... This study was funded by Medtronic. Huygen reported receiving personal fees from Abbott, Saluda, and Grunenthal outside the submitted ...